🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Check our back to back #SITC22 presentations with ⁦Marice Alcantara, PhD⁩ ⁦Sumanta K. Pal, MD, FASCO⁩ ⁦Alex Chehrazi-Raffle, MD⁩ from ⁦City of Hope⁩

We don’t just do great science and fight cancer, we have fun while doing it! SITC Early Career Scientist Committee Society for Immunotherapy of Cancer

So Amazing and Heartwarming. I don't know how you it Nazli Dizman!!! Congratulations ❤️ You are inspiring

2. Previous study by our superstar colleague Nazli Dizman & our team Genitourinary Cancer Research Team @CityofHope showed that the addition of CBM588 to nivo/ipi regimen enhances progression-free survival & response rate in pts with #mRCC. ❓But does CBM588 add to the clinical benefit observed with cabo/nivo?

Signoretti Lab w/ insightful discussion on multiplex immunofluorescence, looking at P.D.-1 Tcells, Tregs, and the integrated PD1 ratio. KidneyCAN Kidney Cancer KCCure

#KIM1 in plasma is a potential biomarker that is useful in many different settings of RCC! Brilliant effort led by Wenxin (Vincent) Xu OncoAlert #KCRS23

Great talk Wenxin (Vincent) Xu on KIM-1 as a biomarker for RCC KidneyCAN

Congratulations Renee Maria Saliby your work is always impressive 👏 🙌 💪

Marice Alcantara, PhD City of Hope presents on another novel strategy to target STAT3 and immunosuppressive myeloid cells in kidney cancer #KCRS23 KidneyCAN. Lots of discussion of macrophages at the meeting this year!

Terrific work by Department of Defense 🇺🇸 grant awardee AlcantaraMarice City of Hope, a brilliant postdoc in the Marcin Kortylewski🇵🇱🇺🇦 lab, who is helping us understand the role of STAT3 in #kidneycancer. Cytokine data done w Nazli Dizman Alex Chehrazi-Raffle, MD et al. #KCRS23

Thank you Toni Choueiri, MD, this means a lot! I have read and been guided by so much of your research

Thank you to my mentors and our team at City of Hope

Goo team!!

Thank you CancerNetwork® for featuring our work presented at #KCRS23 KidneyCAN Check it out 👉"T-Cell and B-Cell Immune Repertoires Differences Associated With ICI Response in Metastatic RCC" cancernetwork.com/view/t-cell-an…

What a great read! It seems interest in myeloid cell targeted therapies has been reinvigorated

Such a great read!!! 😍😍😍😍

👏👏👏👏 Georges Gebrael

It's with great pleasure that I share with you our paper evaluating #cabozantinib with #nivolumab +/- #CBM588 in pts with advanced #kidneycancer, published today in Nature Medicine! 🙏Huge thanks 1st/foremost to patients & their families. Had tons of support from the amazing

Our 1st ⁦City of Hope⁩ GU program retreat was an unforgettable day of science and camaraderie. From immunotherapy to theranostics, microbiome to transcriptomics, we are ready to bring hope to all those with GU cancer as our program expands in CA, AZ, Chicago and Atlanta!